The administration of granulocyte colony-stimulating factor (G-CSF) is known to mobilize hematopoietic stem cells from the bone marrow into the peripheral blood (Demetri and Griffin 1999) and is used to treat neutropenia after cytostatic therapy. The gene discussed is CSF3; the disease is neutropenia.